Plain-English translation of NCT07271186 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing two experimental medications called and to see if they can help protect kidneys that have been damaged by diabetes. Researchers want to learn whether these medications are safe and whether they can slow or reduce kidney damage. Some participants will receive one medication, some will receive both, and some will receive a placebo (inactive pill) to compare results.
Diabetic kidney disease is a serious complication that can lead to kidney failure, but current treatments don't work well enough for everyone. This trial exists to see if this new treatment approach might offer hope to people whose kidneys are being harmed by diabetes.
You likely qualify if…
You likely don't qualify if…
You will visit the research clinic multiple times over the course of the study. At each visit, you'll receive either the new medications or a placebo through injection or infusion, have blood and urine tests to check how your kidneys are responding, and be monitored for any side effects. The study will track how much medication is in your bloodstream and measure changes in your kidney function over time.
AI-generated summary from trial data · Jun 1, 2026 · Not medical advice
United States